why choose us

First received: November 9, 2022

Clinical Trial: Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

Study Status: Completed

Recruit Status: Completed

Condition: Non Small Cell Lung Cancer
Circulating Tumor Cell

Study Type: Observational


Official Title: Clinical Significance of Circulating Tumour Cells in Resectable Lung Cancer Patients

Brief Summary: To determine whether the presence of circulating/disseminated tumour cells (CTCs/DTCs) in the blood and bone marrow of the resectable lung cancer (NSCLC) patients is a negative prognostic factor, and to find correlations with other clinical/pathological disease characteristics.

Read more